COLDSTREAM CAPITAL MANAGEMENT INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1082339
BELLEVUE, WA
Position in REGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$1,447,927
+$22,284 QoQ
Shares Held
1,874
+1.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 60.939167556029886.ToString("F0")%
Shared 0.ToString("F0")%
None 39.060832443970114.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026COLDSTREAM CAPITAL MANAGEMENT INC holds $11,059,687 across 19 Biotechnology names. REGN ranks #2 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,537 | $2,919,031 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
1,874 | $1,447,927 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
3,404 | $643,526 | |
| 4 | INSM |
INSMED Inc
|
3,737 | $611,074 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
8,863 | $572,815 | |
| 6 | OMER |
Omeros Corp
|
54,130 | $571,612 | |
| 7 | MRNA |
Moderna, Inc.
|
8,859 | $450,037 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,351 | $447,005 |
All Filings in REGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,447,927 | 1,874 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $1,425,643 | 1,847 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,139,721 | 2,027 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $574,350 | 1,094 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $848,599 | 1,338 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $933,864 | 1,311 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,376,073 | 1,309 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $1,312,736 | 1,249 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $1,139,588 | 1,184 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,039,017 | 1,183 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $970,269 | 1,179 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $841,410 | 1,171 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $989,290 | 1,204 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $842,700 | 1,168 | Shares | Sole | 2023-01-10 | |
| 2022-06-30 | $558,617 | 945 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $662,102 | 948 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $560,158 | 887 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $249,334 | 412 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $278,711 | 499 | Shares | Sole | 2021-08-16 | |
| 2020-12-31 | $222,230 | 460 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $212,664 | 341 | Shares | Sole | 2020-08-12 | |
| No filing history on record for this holder in this stock. | ||||||